Showing results (1-10 of 107) with videos related to
Sort By:
Pageof 11
The Journal of Clinical Psychiatry|September 1, 1984
Fluphenazine plasma levels and clinical responseM L Mavroidis, D R Kanter, J Hirschowitz, et al.Psychopharmacology|January 1, 1983
Clinical response and plasma haloperidol levels in schizophreniaM L Mavroidis, D R Kanter, J Hirschowitz, et al.Journal of Clinical Psychopharmacology|June 1, 1984
Clinical relevance of thiothixene plasma levelsM L Mavroidis, D R Kanter, J Hirschowitz, et al.Journal of Clinical Psychopharmacology|June 1, 1984
Haloperidol plasma and red blood cell levels and clinical antipsychotic responseD L Garver, J Hirschowitz, G A Glicksteen, et al.Psychopharmacology|January 1, 1984
Adrenergic-receptor desensitization and course of clinical improvement with desipramine treatmentM L Mavroidis, D R Kanter, D N Greenblum, et al.Psychopharmacology|January 1, 1984
Dopamine and non-dopamine psychosesD L Garver, F Zemlan, J Hirschowitz, et al.The American Journal of Psychiatry|August 1, 1981
Physostigmine and lithium response in the schizophreniasP Edelstein, J R Schultz, J Hirschowitz, et al.Archives of General Psychiatry|May 1, 1984
Lithium ratio in vitro. Diagnosis and lithium carbonate response in psychotic patientsD L Garver, R Hitzemann, J HirschowitzLife Sciences|November 1, 1982
Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked eventsD L Garver, C Johnson, D R KanterThe American Journal of Psychiatry|May 1, 1982
Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophreniaJ Hirschowitz, F P Zemlan, D L GarverPageof 11